Drug Information

Drug General Information
Drug ID
D0V9QR
Former ID
DNC000244
Drug Name
Apricitabine
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 3 [522332]
Formula
C8H11N3O3S
Canonical SMILES
C1C(SC(O1)CO)N2C=CC(=NC2=O)N
InChI
1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7-/m1/s1
InChIKey
RYMCFYKJDVMSIR-RNFRBKRXSA-N
CAS Number
CAS 160707-69-7
PubChem Compound ID
455041
PubChem Substance ID
601159, 622289, 10301655, 14749302, 24714758, 57405439, 80831941, 103490242, 104647322, 126663315, 129199918, 134339720, 135199101, 137140580, 142390334, 171579233, 176225506, 187071887, 198983156, 211534875, 215780758, 223554752, 223660730, 224453876, 225848237, 227345431, 251962977
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Modulator
References
Ref 522332ClinicalTrials.gov (NCT00686270) A Long Term Safety Study of Apricitabine in HIV-infected Patients. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.